Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

Last Close
May 01  •  04:00PM ET
2.14
Dollar change
-0.05
Percentage change
-2.28
%
Index
-
P/E
-
EPS (ttm)
-0.47
Insider Own
-
Shs Outstand
854.04M
Perf Week
5.16%
Market Cap
1.83B
Forward P/E
-
EPS next Y
-
Insider Trans
-
Shs Float
22.85M
Perf Month
-7.76%
Enterprise Value
1.82B
PEG
-
EPS next Q
-
Inst Own
0.02%
Perf Quarter
50.70%
Income
-135.51M
P/S
123.07
EPS this Y
-
Inst Trans
10.97%
Perf Half Y
34.79%
Sales
14.85M
P/B
9.25
EPS next Y
-
ROA
-63.77%
Perf YTD
30.49%
Book/sh
0.23
P/C
164.21
EPS next 5Y
-
ROE
-67.95%
52W High
2.50 -14.40%
Perf Year
52.86%
Cash/sh
0.01
P/FCF
252.09
EPS past 3/5Y
17.69% 35.90%
ROIC
-68.33%
52W Low
1.07 100.00%
Perf 3Y
443.56%
EV/EBITDA
-
Sales past 3/5Y
35.00% 16.43%
Gross Margin
1.01%
Volatility
8.31% 8.61%
Perf 5Y
34.59%
EV/Sales
122.46
EPS Y/Y TTM
-679.87%
Oper. Margin
-32.45%
ATR (14)
0.19
Perf 10Y
-
Quick Ratio
1.51
Sales Y/Y TTM
75.04%
Profit Margin
-912.55%
RSI (14)
49.30
Current Ratio
1.53
EPS Q/Q
40.26%
SMA20
-2.32%
Beta
-0.90
Debt/Eq
0.01
Sales Q/Q
25.62%
SMA50
4.97%
Rel Volume
1.41
Prev Close
2.19
Employees
27
LT Debt/Eq
0.00
Earnings
-
SMA200
25.08%
Avg Volume
109.35K
Price
2.14
IPO
Nov 03, 2017
Option/Short
No / Yes
EPS/Sales Surpr.
- -
Trades
Volume
153,733
Change
-2.28%
Apr-27-26 09:00AM
Mar-16-26 08:36PM
Feb-03-26 09:00AM
Feb-18-25 08:30AM
Jul-02-24 07:40AM
06:45AM Loading…
May-30-24 06:45AM
Jan-31-24 04:00PM
Oct-16-23 10:30AM
Apr-27-23 10:30AM
Mar-06-23 04:05PM
Oct-28-22 04:10PM
Aug-17-22 06:00AM
Jan-19-22 05:38PM
Akso Health Group operates a social e-commerce platform principally in China that collaborates with other domestic e-commerce platforms and offers users a wide selection of products. It also plans to develop a new business as a cancer therapy and radiotherapy oncology service provider with operations in the U.S. The firm plans to open 2 vaccine research centers and 100 radiation oncology centers to be located on the east coast serving cancer patients in need of varying stages of treatment, including specialized radiation therapy centers for radiotherapy, personalized consultation, conventional treatment planning, and other cancer related treatment services. The company was founded by Xiaobo An in March 2014 and is headquartered in Qingdao, China.